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BACKGROUND: Several studies suggest that far-ﬁeld transmission (>6 ft) explains a signiﬁcant number of COVID-19 superspreading
outbreaks.
OBJECTIVE: Therefore, quantifying the ratio of near- and far-ﬁeld exposure to emissions from a source is key to better
understanding human-to-human airborne infectious disease transmission and associated risks.
METHODS: In this study, we used an environmentally-controlled chamber to measure volatile organic compounds (VOCs) released
from a healthy participant who consumed breath mints, which contained unique tracer compounds. Tracer measurements were
made at 0.76 m (2.5 ft), 1.52 m (5 ft), 2.28 m (7.5 ft) from the participant, as well as in the exhaust plenum of the chamber.
RESULTS: We observed that 0.76 m (2.5 ft) trials had ~36–44% higher concentrations than other distances during the ﬁrst
20 minutes of experiments, highlighting the importance of the near-ﬁeld exposure relative to the far-ﬁeld before virus-laden
respiratory aerosol plumes are continuously mixed into the far-ﬁeld. However, for the conditions studied, the concentrations of
human-sourced tracers after 20 minutes and approaching the end of the 60-minute trials at 0.76 m, 1.52 m, and 2.28 m were only
~18%, ~11%, and ~7.5% higher than volume-averaged concentrations, respectively.
SIGNIFICANCE: This study suggests that for rooms with similar airﬂow parameters disease transmission risk is dominated by nearﬁeld exposures for shorter event durations (e.g., initial 20–25-minutes of event) whereas far-ﬁeld exposures are critical throughout
the entire event and are increasingly more important for longer event durations.
IMPACT STATEMENT:
●

We offer a novel methodology for studying the fate and transport of airborne bioaerosols in indoor spaces using VOCs as
unique proxies for bioaerosols. We provide evidence that real-time measurement of VOCs can be applied in settings with
human subjects to estimate the concentration of bioaerosol at different distances from the emitter. We also improve upon the
conventional assumption that a well-mixed room exhibits instantaneous and perfect mixing by addressing spatial distances
and mixing over time. We quantitatively assessed the exposure levels to breath tracers at alternate distances and provided
more insights into the changes on “near-ﬁeld to far-ﬁeld” ratios over time. This method can be used in future to estimate the
beneﬁts of alternate environmental conditions and occupant behaviors.

Keywords: Bioaerosol; COVID-19; Healthy buildings; Risk; Infectious disease; PTR-ToF-MS
Journal of Exposure Science & Environmental Epidemiology; https://doi.org/10.1038/s41370-022-00499-6

INTRODUCTION
The spread of COVID-19 has caused extensive death and
damage to the lives of millions of people worldwide. Severe
acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the
causative agent of COVID-19, is transmitted from human to
human via bioaerosol particles that are released during
respiratory activities such as breathing, talking, singing, and
coughing [1–3].

Epidemiological studies, public health research, and engineering risk assessment models of well-documented outbreaks
indicate the important role that exposures beyond 2 m plays in
COVID-19 disease transmission [3–10]. Therefore, quantifying the
degree of exposure to bioaerosols according to distance from the
source emitter is critical to characterize disease transmission risk
more accurately, to determine the most effective environmental
and human related risk reduction strategies such as ventilation,
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ﬁltration, spatial distancing, and masking to reduce disease
transmission.
A well-mixed air space is a conventional assumption that has
been used in most studies of indoor air pollution and infectious
disease transmission modeling [11]. For a well-mixed condition,
indoor air contaminants, including virus laden aerosol particles,
are assumed to be uniformly distributed by appropriate ventilation, interior mixing fans, buoyancy driven ﬂows, and inﬁltration,
immediately after being emitted from the source [12]. However,
thermal stratiﬁcation, low mixing ﬂow rates from ventilation, and
other environmental conditions can cause a non-uniform distribution of bioaerosols in indoor spaces [13, 14], where the
probability of susceptible occupants inhaling virus-laden aerosol
particles will rely, at least to some extent, on the distance from the
source emitter. Moreover, the well-mixed assumption does not
address sequences of mixing over time relative to emission rates
and spatial parameters.
Few studies have considered the importance of spatial
parameters such as room height into measurements of indoor
pollutants [15–18]. A study of temporal and spatial scales suggests
that chemical compounds as well as particles in the range of 1 µm
−10 µm with persistent residence time exhibit spatial gradients
that are signiﬁcantly controlled by ventilation rates [19]. Additionally, controlled experiments with subjects diagnosed with
COVID-19 were used to study the abundance of SARS-CoV-2 viral
RNA copies in room aerosols. The authors found that the near-ﬁeld
was associated with a higher number of virus RNA copies, and
statistically higher carbon dioxide (CO2), and particle counts of
0.3 µm – 2.5 µm than in the far-ﬁeld [3]. Differences between nearﬁeld and far-ﬁeld were also examined through the comparison of
CO2 and particles with patients receiving high-ﬂow nasal cannula
therapy (HFNC), where the CO2 concentration was statistically
higher at a distance 0.5 m (~1.6 ft) from the source emitter
compared to background levels [20].
CO2 has been historically used as a tracer for estimating the
concentration of human sourced indoor air contaminants as well as
outdoor ventilation rate, and more recently discussed in the context
of aerosol transmission of infectious disease [21, 22]. While CO2 can
be a useful metric for estimating the rate of outdoor air intake, it
cannot be applied as a uniquely identiﬁable bioaerosol tracer from a
speciﬁc source emitter in a room with multiple people.
Real-time measurement of tracer compounds uniquely associated with an individual’s emitted breath offers the ability to
directly study the transport, mixing, and exposure implications of
exhaled breath constituents (e.g., pathogens) from only those
individuals tagged as infectious. In this pilot study, we “tag” the
individual’s respiratory emissions with high quantities of volatile
tracers (emitted from breath mints) to serve as a proxy
measurement of exposure of susceptible individuals to the
“infected” individual’s respiratory emissions. The capability to
measure tracers unique to only infectious individuals extends and
complements exposure studies that have historically relied on CO2
to estimate rebreathed fractions of exhaled breath from all
occupants in the space. Since both infectious and susceptible
occupants emit CO2 and contribute to the rebreathed fraction, a
large proportion of exhaled CO2 does not represent a potential
risk of infection. Our approach allows measurement of a proxy of
the contribution of respiratory emissions from infectious occupants. Our approach also offers the potential to study the
dynamics of exposure risk by monitoring the “tagged” tracer
concentrations in realistic indoor spaces occupied by any number
of individuals, and any subset of infectious individuals, through
high time resolution measurements of VOCs throughout an indoor
space. These measurements enable study of transport and mixing
effects on exposure to exhaled breath tracers in complex ﬂuid
ﬂows empirically. This is in contrast to commonly used models,
e.g., the Wells-Riley [23] model, that rely on an assumption of
perfect mixing in the space.
SPRINGER NATURE

The goals of the present study are to (a) determine the
effectiveness of tracer compounds sourced from breath mints
consumed by a participant and (b) to better characterize the
impact of distance from the emission source on distribution of
exhaled bioaerosol in an indoor environment.

METHODOLOGY
Background
A previous study has shown that chewing peppermint ﬂavored
gum is associated with release of unique volatile organic
compounds (VOCs) such as menthone and menthol, with source
strength dependent on oral activity and chewing frequency [24].
Real-time measurements of VOCs can provide useful information
for studying pollutant dynamics of indoor environments [25]. We
used proton transfer reaction - time of ﬂight - mass spectrometry
(PTR-ToF-MS) to measure VOCs associated with breath mints
across a mass range of 17–490 amu with 1 second time resolution.
PTR-ToF-MS
The principles of the PTR-ToF-MS measurements have been
described previously [26–28].This approach allows for a real-time
measurement of VOCs with a proton afﬁnity greater than that of
H2O. In theory, ionization is soft, allowing for little fragmentation,
and compound identiﬁcation can be made by observation of the
[M + H] + ion (i.e., molecular mass + the mass of the transferred
proton). Our study used breath mints instead of chewing gum to
monitor compounds that are predominantly associated with
breath emissions from the mint: menthone, monoterpenes, and
menthol. These compounds were shown to be substantially
elevated in exhaled breath of the participant when consuming a
breath mint. We putatively identify the signal m/z 155.150 as
protonated menthone and m/z 139.137 as dehydrated menthol
[29, 30]. Monoterpenes are a class of compounds that share the
chemical formula C10H16; our PTR-ToF-MS is unable to distinguish
isomers. We report monoterpenes as the sum of signals m/
z = 137.144 and the known fragment m/z = 81.070; our study was
conducted under similar ionization conditions to prior studies that
show monoterpenes fragmentation at these signals without
interferences [31, 32]. We sum the concentration from those two
ions and report as monoterpenes.
Participant recruitment
Human subject protocols were reviewed and approved by the
University of Oregon Institutional Review Board (IRB) (Protocol
#20210509). One human subject participated in this study. The
participant was a 25–30 year old male with a height of 1.89 m
(6.1 ft) and a sitting height of 1.2 m (3.6 ft). The participant was
instructed to:
–
–
–
–

not use cologne or body sprays during the day preceding and
during the study period;
wear clothes that were not recently washed with detergents;
follow a consistent diet during the course of three data
collection days;
maintain a constant breath mint consuming rate during all
trials.

Climate chamber
Experiments were conducted at the Energy Studies in Buildings
Laboratory, Portland, OR, USA, using a custom environmentallycontrolled climate chamber with an interior volume of 27 m3
(Fig. 1A). Filtered air was supplied from the lab’s environment
through a ceiling plenum and exhausted to the lab’s environment
through a ﬂoor plenum. Both supply and exhaust air were ﬁltered
by activated carbon beds. Air was exchanged at ~3 air changes
per hour (ACH) during test periods and ﬂushed at >20 ACH for a
Journal of Exposure Science & Environmental Epidemiology
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Fig. 1 Digital model of the Experimental setup indicating. A climate chamber, airﬂow distribution, as well as sampling location for each
unique trial (modeled in Rhinoceros software), (B) experimental procedure and the number of breath mints consumed by the participant for
each trial.
Table 1.
Trials

Summary of all experiment trials.
Sampling probe distance from the
participant’s mouth

Number of
replicates

Sampling
frequency (Hz)

Sampling duration
(minutes)

Number of
samples
3600

A

0.76 m (2.5 ft)

2

1

60

B

1.52 m (5 ft)

2

1

60

3600

C

2.28 m (7.5 ft)

2

1

60

3600

D

Exhaust

2

1

60

3600

E

Breath mint in a 250 ml glass container

1

1

20

1200

F

Breath mint exhaled into a 250 ml glass
container

1

1

20

1200

minimum of 20 minutes between trial periods. Three air changes
per hour was selected to ensure that steady-state conditions
would be approached by the end of each 60-minute trial. We
observed the concentration of breath tracers during the experiment to conﬁrm the removal of previous residuals before the
beginning of each trial.
Ambient indoor air was supplied through a MERV-13 pre-ﬁlter
and high-ﬂow activated carbon ﬁlters (Air Box 4 Stealth; AirBox
Filters, Laval, Quebec, CA) and exhausted through an identical
ﬁltration system (shown as supply ﬁlter package and return ﬁlter
package in Fig. 1A). Air change rate was monitored throughout
the experiment using in-duct thermal anemometer probes and
multi-function ventilation meters (#964 and #9565-P, respectively;
TSI Incorporated, Shoreview, MN, USA).
Experimental procedure
Each trial began with adjustment of the climate chamber’s
ventilation rate to the maximum value (20 ACH) for a minimum
duration of 20 minutes without the presence of the participant in
order to evacuate residual VOCs from prior trials (Fig. 1B). We
monitored the concentration of menthone to assure it reached a
negligible steady-state background concentration. Next, the
participant was instructed to enter the chamber, sit in a chair,
and breathe normally for ﬁve minutes without consuming any
Journal of Exposure Science & Environmental Epidemiology

breath mints. These 5-minute periods provided a baseline
reference for each trial and were included in the study protocol
to identify certain compounds that are exclusively associated with
natural human breath and not breath mint ﬂavoring, and to
additionally provide a baseline to observe any exhaled compounds that may have remained in the participant’s mouth from
previous trials. After 5 minutes, the participant was visually
informed to begin consuming one breath mint every 10 minutes
(Fig. 1B), resulting in 6 breath mints consumed during each 1-hour
trial (minutes 0, 10, 20, 30, 40, and 50). Through some qualitative
experiments, we identiﬁed that it takes ~10 minutes until 1 mint is
fully dissolved in the participant’s mouth while sitting and
breathing normally. Therefore, the participant was instructed to
consume breath mints as consistently as possible (without
chewing) during 10-minute intervals controlled by a timer. All
breath mints were carried into the chamber by the participant in
an air sealed plastic bag. To keep emissions relatively constant, the
participant was instructed to remain silent and minimize body
movement during the entire course of study. The participant also
maintained a resting activity level between trials to avoid emission
irregularities while inside the chamber during the trials.
A summary of all trials conducted in this study is presented in
Table 1. We used a single sampling line attached to a portable
tripod at participant’s breathing zone level (1.2 m) and moved the
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Table 2.

Comparison of the ﬁrst and last minute of baseline period for ﬁve major compounds (paired t test) for trials A-C (Table 1).
Sampling distance from human source emitter (n = 60)

Compounds

0.76 m (2.5 ft)

1.52 m (5 ft)

Menthone

0.0005(p = 0.92)

−0.005 (p = 0.32)

2.28 m (7.5 ft)

Menthol

0.0086(p = 0.46)

0.02 (p = 0.35)

−0.019 (p = 0.07)

Monoterpenes

0.01 (p = 0.1)

0.0015(p = 0.78)

0.0015 (p = 0.76)

−0.0015 (p = 0.79)

Isoprene

0.07(p < 0.005)

−0.055 (p < 0.001)

−0.049 (p < 0.001)

Acetone

0.59(p < 0.001)

−0.59 (p < 0.001)

−0.34 (p < 0.001)

probe after each 1-hour trial to designated spots on the ﬂoor,
measuring 0.76 m (2.5 ft), 1.52 m (5 ft) and 2.28 m (7.5 ft) from the
participant’s mouth (Table 1, Trials A-C). Additionally, we placed
another sampling line of equal length inside the ﬂoor plenum
exhaust duct (called exhaust trials) to measure exhaust air as the
volume-averaged concentration (Table 1, Trial D). Each trial
(Table 1, trials A-D) lasted for 1-hour during which PTR-ToF-MS
continuously measured VOCs at 1-second resolution, resulting in
3600 samples for each trial. For each location, we measured the
concentration of VOCs in duplicate trials with random order over
the course of a 3-day sampling period. The concentrations of each
compound for duplicate trials at each sampling location were
averaged to produce a single data set for each of the distance
trials (0.762 m, 1.524 m, 2.28 m, and exhaust trials).
In addition to trials A-D (Table 1), we conducted two other
experiments to conﬁrm the presence of unique tracer compounds
associated with the exhaled breath of the participant consuming
breath mints (Table 1, Trials E&F). In order to conﬁrm which
compounds were natively sourced from the breath mint we
conducted trial E. In Trial E we placed one single breath mint in
the headspace of a 250 mL glass container for ~1 minute and
monitored the concentration of VOCs over a 20-minute period. For
similar reasons, for trial F the participant was instructed to
consume one breath mint while breathing normally into the same
250 mL glass container for ~1 minute. For both trial E and F
(Table 1), we monitored the concentration of VOCs over a 20minute period using PTR-ToF-MS sampled at a ﬂowrate of ~100
cc/min during the experiments. Three minutes of background
(BCK) measurements were taken prior to the start of the
experiment.
Statistical analysis
Analyses were performed using the statistical programming
environment R. The Taylor expansion [33] procedure was applied
using the propagate package [34] to calculate the expanded
uncertainties associated with VOC measurements. The ratio of
samples collected at 0.76 (2.5 ft), 1.52 (5 ft), and 2.28 m (7.5 ft) were
normalized by the volume-averaged concentration (VAC) resulting
in a series of magniﬁers for each distance expressed in percentage
values. The effect size associated with each magniﬁer was
assessed using the Cohen’s d test [35, 36].
RESULTS
Menthone, menthol, monoterpenes, isoprene, and acetone were
considered for analysis. We conducted paired t test analyses
between the ﬁrst and last minute of baseline periods during which
the participant did not consume breath mints in the chamber
(n = 60). Table 2 presents the results of paired t-tests between the
ﬁrst and last minute of the baseline periods for each distance. The
concentration of menthone, menthol, and monoterpenes did not
change (p > 0.05) during baseline periods when the participant did
not consume breath mints, while the concentration of isoprene
and acetone changed during the baseline periods. This indicates
that acetone and isoprene were detected in the participant’s

SPRINGER NATURE

natural breath which is consistent with previous ﬁndings [37].
However, changes in isoprene and acetone were inconsistent with
breath sources only, suggesting other indoor sources such as the
participant’s skin and climate chamber interior materials may have
contributed to the variability. Therefore, we summed the
concentrations of menthone, menthol, and monoterpenes as a
unique breath tracer for the comparison of different distances in
this study.
In addition to the analysis of baseline periods presented in
Table 2, the presence of menthone, menthol, and monoterpenes
in the exhaled breath of the participant while consuming breath
mints was additionally conﬁrmed through trials E & F (Table 1),
occurring in a 250 mL glass ﬂow-through glass chamber. Figure 2
indicates that the concentrations of menthone, menthol, and
monoterpenes substantially increase when the breath mint was
placed in the headspace of a 250 ml container (Fig. 2A), and when
the participant breathed naturally into the 250 ml container while
consuming the mint (Fig. 2B). We subsequently refer to the
summation of the above-mentioned signals (menthone, menthol,
and summed monoterpenes) as “breath tracer compounds.” We
estimated the emission rate of breath tracer compounds for the
ﬁrst ~30 seconds of trials E & F (Table 1) as VOCs accumulated in
the 250 mL ﬂow-through glass chamber at ~4.8 air change per
minutes (Fig. 2B). We estimate the emission rate of breath tracer
compounds to be ~130 µg/h (monoterpenes = 90 µg/h,
menthone = 37 µg/h, and menthol = 5 µg/h). These values are
an order of magnitude greater than the total endogenous
emission of these species determined by Wang et al. [38],
implying measured breath tracer compounds here are the
dominant emissions from the subject.
Furthermore, Supplementary Fig. 1 shows the concentration of
major VOCs during ventilation and baseline periods, indicating
low but not necessarily zero concentrations for trials A-D (Table 1).
We hypothesize that baseline concentrations are associated with
residual VOCs that were adsorbed by climate chamber or
ventilation ﬁlter surfaces and slowly re-emitted into the chamber
air (Supplementary Table 1). To make a more consistent starting
point for all trials, we subtracted the average concentration of
each compound detected during baseline periods (minutes −5
to 0) from the 1-hour trials (minutes 0–60). A comparison of
summed breath tracer compounds normalized by the volumeaveraged concentration is shown for each distance in Fig. 3.
Table 3 reports on the magniﬁers, expanded uncertainties
associated with each value, as well as Cohen’s d effect size
statistics for each distance. Supplementary Figure 2 demonstrates
the uncertainties associated with the values presented in Fig. 3.
Supplementary Figure 3 shows the time series concentration of
breath tracer compounds over time for all 4 locations.
DISCUSSION
We used PTR-ToF-MS to trace the concentration of breath tracer
compounds associated with a consumed breath mint as a proxy
for bioaerosol emissions from a healthy participant during each
60-minute trial. For each trial, we summed the concentrations of
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menthone, sum of monoterpenes, and menthol at the resolution
of each sample as a unique breath tracer since they were detected
only when the participant consumed breath mints. The summed
tracer concentrations detected at 0.76 m (2.5 ft), 1.524 m (5 ft), and
2.28 m (7.5 ft) from the participant were normalized by VAC, which
indicates the magniﬁer of each location compared with an
approximate well-mixed condition. As shown in Fig. 3, the
concentration of VOCs at 0.76 m (2.5 ft) and 1.524 m (5 ft) remain
above VAC during the ﬁrst 5 minutes of the study, while the
concentration at 2.28 m (7.5 ft) begins to approach the VAC after
minute ~10 and exceed the VAC by minute ~20 (Fig. 3). We
observed a steep increase in the concentration of breath tracer
compounds at 0.76 m (2.5 ft), 1.52 m (5 ft), and 2.28 m (7.5 ft)
during the ﬁrst ﬁve minutes, which indicates that signals at short
Journal of Exposure Science & Environmental Epidemiology

distances exceeded those measured at the exhaust plenum, likely
due to a concentrated exhaled plume that had not mixed
extensively throughout the chamber. At minute 5, the concentration of breath tracer compounds also began to rise in the exhaust
plenum (VAC), resulting in decreases in the ratios (multipliers) of
indoor sampling locations normalized by the VAC (Fig. 3). Shortly
after minute 10, the concentration of breath tracer compounds
during 0.762 m (2.5 ft) trials exceed the VAC, resulting in a higher
concentration at 0.762 m (2.5 ft) during minutes 5–20 compared to
all other locations and having a 36–44% higher concentration
than VAC. This ﬁnding suggests that the risk of exposure to virusladen aerosol particles during the ﬁrst 20 minutes in close vicinity
of a source within a space similar to our chamber is relatively
higher for close contact distances (less than 0.91 m) when
SPRINGER NATURE
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Table 3. Magniﬁer, effect size (Cohen’s d), and expanded uncertainty (Taylor Expansion) values 0.762 m (2.5 ft), 1.524 m (5 ft), 2.28 m (7.5 ft)
normalized by volume-averaged concentrations in 5 minutes time step.
0.762 m (2.5 ft)
Intervals

Magniﬁer

1.52 m (5 ft)
Effect size*

±EU2

Magniﬁer

2.28 m (7.5 ft)
Effect size*

±EU2

Magniﬁer

0.14 (N)

Effect size*

±EU2

Min_0_60

1.21

0.32 (s)

0.34

1.07

0.32

1.05

0.1 (N)

0.3

Min_0_5

2.74

0.57(M)

4.68

1.72

−0.08(N)

3.49

0.73

−0.58(M)

1.88

Min_5_10

0.89

−0.26(S)

0.5

0.68

−0.95(L)

0.51

0.65

−1.12(L)

0.43

Min_10_15

1.36

1.96(L)

0.42

0.94

−0.42(S)

0.34

0.87

−0.93(L)

0.30

Min_15_20

1.44

3.65(L)

0.37

1.02

0.09(N)

0.31

0.97

−0.28(S)

0.27

Min_20_25

1.25

2.00(L)

0.3

1.17

1.32(L)

0.29

1.14

1.07(L)

0.26

Min_25_30

1.12

1.39(L)

0.23

1.02

0.23(S)

0.22

1.11

1.08(L)

0.21

Min_30_35

1.19

2.13(L)

0.25

1.16

1.78(L)

0.25

1.16

2.12(L)

0.22

Min_35_40

1.17

2.00(L)

0.23

1.12

1.35(L)

0.21

1.12

1.41(L)

0.21

Min_40_45

1.19

2.54(L)

0.2

1.16

2.27(L)

0.21

1.13

1.88(L)

0.19

Min_45_50

1.15

2.39(L)

0.18

1.1

1.71(L)

0.18

1.06

1.01(L)

0.17

Min_50_55

1.21

2.76(L)

0.25

1.14

2.01(L)

0.21

1.06

0.92(L)

0.2

Min_55_601

1.18

2.39(L)

0.25

1.11

1.49(L)

0.21

1.07

1.03(L)

0.17

*N = negligible effect size, S = small effect size, M = medium effect size, L = large effect size.
1
= Steady-state period.
2
= Expanded uncertainty.

compared with other distances. Meanwhile, the concentration of
breath tracer compounds at 1.52 m (5 ft) and 2.28 m (7.5 ft) also
rise above VAC during minutes 20–25, with the greatest magniﬁer
having a value 17% higher than the VAC at 1.52 m (5 ft). After
25 minutes, tracer concentrations at all distances maintained a
relatively consistent relationship relative to the VAC. However,
sampling locations further from the occupant progressively
approached background concentrations. The magniﬁers during
the ﬁnal 5-minutes of experiments were ~18% (±25%, Cohen’s d
estimate = Large), ~11% (±21%, Cohen’ s d estimate = Large), and
7.5%(±18%, Cohen’ s d estimate = Large) above VAC at 0.76 m
(2.5 ft), 1.52 m (5 ft), and 2.28 m (7.5 ft), respectively. The expanded
uncertainties associated with values reported in Table 3 are in
agreement with previous studies that measured VOCs using PTRToF-MS [39]. Despite the fact that Cohen’s d statistics show large
effect size values when the concentration of breath tracer
compounds at 0.76 m (2.5 ft), 1.52 m (5 ft), and 2.28 m (7.5 ft)
were compared to VAC [40], the uncertainty associated with our
measurements suggest that reported magniﬁers presented in
Table 3 should be studied further with more replicates to improve
the accuracy of, and conﬁdence in, the near-ﬁeld to far-ﬁeld
multipliers. Meanwhile, these ﬁndings highlight the importance of
both near-ﬁeld and far-ﬁeld exposure events and emphasize the
importance of exposure duration in consideration of near-ﬁeld
and far-ﬁeld mitigation priorities. In this study, and given these
room characteristics and airﬂow rates, the airborne disease
transmission risk associated with the initial period of source
emissions appears to be dominated by near-ﬁeld exposures,
whereas far-ﬁeld exposure risks are increasingly important as the
event precedes.
The implications of magniﬁers in a real-world case study
The purpose of this section is to compare the results of near
-ﬁeld and far-ﬁeld magniﬁers for the present study and two
recent relevant studies [3, 20]. In one study [20] the team
measured near-ﬁeld and far-ﬁeld CO2 concentrations to estimate
magniﬁers in patient rooms within a healthcare environment
having 8–11 ACH. The authors reported background (far-ﬁeld)
CO2 concentrations of 580 ppm (mean across 7 patients) and
reported near-ﬁeld mean CO2 concentrations of 605 ppm, thus
only 25 ppm higher than background, which equates to a nearSPRINGER NATURE

ﬁeld magniﬁer of 4.3% [20]. We note that the uncertainty in CO2
measurements for most systems reported in the literature is
±50 ppm.
A second study focused on bioaerosols emitted from individuals
diagnosed with COVID-19 within a space having similar environmental conditions as the chamber used for the present study
(Supplemental Table 2) [3]. Near-ﬁeld (1.2 m, 4 ft) and far-ﬁeld
(3.5 m, 11 ft) designations were used to report the concentration
of SARS-CoV-2 viral RNA in room aerosols, CO2, and particles in the
range of 0.3–25 µm. We translate their data into near-/far-ﬁeld
ratios to provide a comparison with the near-ﬁeld magniﬁers
reported in Fig. 3 of the present study. The near-/far-ﬁeld ratios
from the previous study (Supplemental Table 3) ranged from
~8–12% for CO2 and particles (1–2.5um), which correspond
reasonably well with the near-ﬁeld magniﬁers of the present
study (Fig. 3), where the concentration of targeted VOCs in the
near-ﬁeld (0.762 m) was ~10% higher than far-ﬁeld (2.28 m) during
steady-state periods.
In summary, the concentration of CO2 and the particles of 1 µm
– 2.5 µm in the controlled study on participants who were
diagnosed with COVID-19 [3] were ~8% and ~12% higher in the
near ﬁeld, 1.2 m (4 ft), compared to the far ﬁeld, 3.5 m (11 ft),
respectively [3]. The concentration of targeted VOCs in the nearﬁeld (0.762 m) was ~10% higher than the far-ﬁeld (2.28 m) during
steady-state periods, thus- providing greater conﬁdence for the
concept of breath tracers as a proxy for virus laden bioaerosols.
DISCUSSION AND LIMITATIONS
Our study provides evidence that a novel breath tracer approach
has utility in bioaerosol experiments when paired with a PTR-ToFMS. This study also provides a series of magniﬁers that could be
used to estimate the concentration of bioaerosols at 0.76 m (2.5 ft),
1.52 m (5 ft), and 2.28 m (7.5 ft) from a human emitter in a
reasonably well-mixed indoor space with conditions similar to
those used in chamber experiments described in this paper. While
these magniﬁers are speciﬁc to this environmental chamber and
ventilation pattern, the methodology can support future microbial
risk assessment models that superimpose near-ﬁeld exposures
and inhalation dose on far-ﬁeld exposures estimated using a wellmixed assumption.
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Our ﬁndings suggest that the concentration of bioaerosols in
the far-ﬁeld is relatively close to the volume-averaged concentration at steady-state, while close range distances are associated
with relatively higher exposure levels during the ﬁrst 20 minutes
of an emission exposure event.
Our study was a pilot project with several limitations. Our data
were limited to duplicate trials and a constant ventilation rate of
~3 ACH in a chamber with a speciﬁc volume, ventilation system,
and environmental conditions. Future research should include
variations in related chamber conditions as well as multiple
human participants in controlled settings to study the impact of
occupant related factors such as thermal plumes and human
motions on the concentration and dispersion of tagged breath
tracers around people’s breathing and alternate positions.
Ventilation strategies other than overhead (used in this experiment) should be considered with different ACH in future efforts.
We seek to study several other distances & positions from the
source emitter (vertical and horizonal distribution) to improve the
accuracy of magniﬁers with the intention of developing a
comprehensive heterogeneous air space model for indoor air
quality research.
DATA AVAILABILITY
All data and code supporting this study and required to create the analyses are
provided in Github, available at https://github.com/BioBE/Breath_Tracer.
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